NLS PHARMACEUTICS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1684 USD | -5.61% |
|
-37.65% | -71.45% |
Chart calendar NLS Pharmaceutics AG
d742d4329c247b60549e5930a1253._J_oaHlgmR73HU6z0ZCNKdxk73naAKuyXAPl7koJWEo.kMeRLUku9XaEcATc6aD_c64-vwybOMf9HnqCsSxqbzy2zbswTS_JV9olOQ~ef8505fc2b2411ae9f91e65c314a5809
Upcoming events on NLS Pharmaceutics AG
No events available
Past events on NLS Pharmaceutics AG
| 30/05/2024 17:30 | American Society of Clinical Psychopharmacology Meeting |
| 01/12/2023 15:30 | Oppenheimer Sleep Disorders Summit |
| 06/07/2023 16:00 | Business Update Call |
| 30/06/2023 15:00 | Annual General Meeting |
| 20/06/2023 15:30 | Maxim Group Virtual Healthcare Conference |
| 06/06/2023 22:00 | American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 328 |
| 06/06/2023 17:00 | American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 329 |
| 06/06/2023 17:00 | American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 327 |
| 05/06/2023 17:00 | American Academy of Sleep Medicine and Sleep Research Society Meeting - Poster Number: 57 |
| 05/06/2023 16:15 | American Academy of Sleep Medicine and Sleep Research Society Meeting |
| 29/05/2023 | American Society of Clinical Psychopharmacology Meeting |
| 13/03/2023 17:00 | Roth Conference |
| 11/03/2023 | BIO CEO & Investor Conference |
| 31/01/2023 15:00 | R&D Day |
| 30/09/2022 15:00 | Investor Meeting - Key Opinion Leader |
| 28/04/2022 21:00 | B Riley Securities Virtual Neurology & Ophthalmology Conference |
| 30/03/2022 19:00 | Maxim Group Virtual Growth Conference |
| 03/03/2022 20:00 | SACHS European Life Sciences Virtual CEO Forum |
| 13/02/2022 | BIO CEO & Investor Conference - One-on-One Meetings |
| 05/10/2021 14:00 | MicroCap Rodeo- Fall Harvest Best Ideas Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -4,20 | -2,30 -2,38 3.38% | -11,9 -9,63 -23.13% | -15,5 -14,1 -9.73% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -2,86 -2,40 -19.03% | -11,9 -9,79 -22.06% | -16,5 -14,8 -11.3% |
|
Net income Million USD | Released Forecast Spread | -5,45 | -2,86 -2,56 -11.89% | -11,9 -9,73 -22.81% | -16,5 -14,1 -16.74% |
|
EPS USD | Released Forecast Spread | 0,00 | -0,41 -0,36 -13.89% | -1,00 -0,75 -33.33% | -0,84 -0,55 -53.66% |
| Announcement Date | 31/08/20 | 14/05/21 | 24/03/22 | 05/05/23 |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2022 S1 | 2022 S2 | 2023 S1 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | ||
|
EBIT Million USD | Released Forecast Spread | -1,22 -1,30 6.19% | -8,69 -7,68 -13.07% | -6,79 -9,40 27.72% | -7,55 -9,06 16.64% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,64 -7,71 -12.07% | -7,85 -9,40 16.44% | -7,61 -9,06 15.95% | ||
|
Net income Million USD | Released Forecast Spread | -1,23 | -1,63 -1,48 -10.18% | -8,64 -7,71 -12.07% | -7,85 -9,40 16.44% | -7,61 -9,06 15.95% |
|
EPS USD | Released Forecast Spread | -0,18 | -0,23 -0,19 -21.05% | -0,54 -0,39 -38.46% | -0,30 -0,30 0% | -0,20 -0,27 25.93% |
| Announcement Date | 19/10/20 | 14/05/21 | 11/10/22 | 05/05/23 | 06/12/23 |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for NLS Pharmaceutics AG
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NLSP Stock
- Calendar NLS Pharmaceutics AG
